ERA

Download the full-sized PDF of Melatonin for cognitive impairment (Protocol)Download the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R3VM4343T

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Nursing, Faculty of

Collections

This file is in the following collections:

Chronicity

Melatonin for cognitive impairment (Protocol) Open Access

Descriptions

Author or creator
Rusak-Maguire, A.
Forbes, D.
Additional contributors
Subject/Keyword
Melatonin
Cognitive impairment
Type of item
Journal Article (Published)
Language
English
Place
Time
Description
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is a systematic review of evidence relating to clinical efficacy and safety of melatonin in treatment of manifestations of dementia or cognitive impairment (CI).
Date created
2002
DOI
doi:10.7939/R3VM4343T
License information
Rights
© 2002 The Cochrane Collaboration for John Wiley & Sons, Ltd. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.
Citation for previous publication
Rusak-Maguire A, Forbes D. (2002). Melatonin for cognitive impairment (Protocol). The Cochrane Database of Systematic Reviews, Issue 2, Art. No.: CD003802. DOI: 10.1002/14651858.CD003802.
Source
Link to related item

File Details

Date Uploaded
Date Modified
2014-04-29T19:22:15.698+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 261911
Last modified: 2015:10:12 19:32:19-06:00
Filename: CDSR_2002_CD003802_Protocol.pdf
Original checksum: 5fa3f201f8d41740a867498b19e30c6e
Well formed: true
Valid: true
Page count: 11
Activity of users you follow
User Activity Date